General Information of the Compound
Compound ID |
CP0066128
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine
Show/Hide
|
||||||||||||||||||
Synonyms |
A-91033
Antiallersin
Aprobit
Atosil (TN)
Avomine
Avomine (TN)
Camergan
Dimapp
Dimethylamino-isopropyl-phenthiazin
Dimethylamino-isopropyl-phenthiazin [German]
Diphergan
Diprazin
Diprazine
Diprozin
Fargan
Fargan (TN)
Farganesse (TN)
Fenazil
Fenetazina
Fenetazine
Genphen
Hiberna
Histargan
Iergigan
Isophenergan
Isopromethazine
Lercigan
Lergigan
Lergigan (TN)
Lilly 01516
Lilly 1516
Metaryl
Pelpica
Phargan
Phenargan
Phenergan (TN)
Phenerzine
Phenoject-50
Phensedyl
Pilothia
Pilpophen
Pipolphene
Pro-50
Proazaimine
Proazamine
Procit
Promacot
Promazinamide
Promergan
Promesan
Prometasin
Prometazin
Prometazina
Prometazina [INN-Spanish]
Prometazine
Prometh
Promethacon
Promethaine
Promethazin
Promethazine
Promethazine (JAN/INN)
Promethazine [INN:BAN]
PromethazineHcl
Promethazinum
Promethazinum [INN-Latin]
Promethegan
Promethegan (TN)
Promethiazine
Promezathine
Prorex
Protazine
Prothazin
Prothazine
Prothiazine (TN)
Provigan
Pyrethia
Pyrethiazine
RP 3277
Receptozine (TN)
Remsed
Romergan
Romergan (TN)
Rumergan
SKF 1498
Tanidil
Thiergan
Valergine
Vallergine
WY 509
Zipan-25
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C17H20N2S
|
||||||||||||||||||
Molecular Weight |
284.428
|
||||||||||||||||||
Canonical SMILES |
CC(CN1c2ccccc2Sc2ccccc12)N(C)C
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C17H20N2S/c1-13(18(2)3)12-19-14-8-4-6-10-16(14)20-17-11-7-5-9-15(17)19/h4-11,13H,12H2,1-3H3
Show/Hide
|
||||||||||||||||||
InChIKey |
PWWVAXIEGOYWEE-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
73745-50-3
38878-40-9
60-87-7
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02591, Major prion protein
Protein ID: PT01065, Serine/threonine-protein kinase mTOR
Protein ID: PT03795, Solute carrier family 22 member 1
Protein ID: PT02031, Voltage-dependent N-type calcium channel subunit alpha-1B
Clinical Information about the Compound
Drug 1 ( Promethazine )
Drug Name | Promethazine | ||
---|---|---|---|
Company | Wyeth Pharmaceuticals | ||
Indication | |||
Target(s) |
Histamine H1 receptor (H1R)
Antagonist
|